On Friday, September 28, the European Commission announced that it has set a deadline of November 6 for its decision on Japanese pharmaceutical company Takeda’s US$62 billion takeover of UK Shire.
The proposed deal has already received unconditional approval from the US, Brazil, and China. The EU may approve the deal as-is, with conditions, or open a four month probe if there are serious concerns.
Also on Friday, Takeda announced that its shareholders will vote on October 19 on the Shire acquisition.
Full Content: The Pharma Letter, Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 216.73.216.118
Please verify email or join us
to access premium content!
